MAP - Market Access Podcast

By Dr. Stefan WalzerBusiness Science Medicine Health & Fitness

MAP - Market Access Podcast episodes

February 15, 2022 The private health insurances as the entrance into German market access – is this true, Dr. Bastian Biermann?
The German health care system consists of the statutory and private health insurances, whereas the latter covers around 10% of the population. Anyhow, access and commercialization, especially of new and innovative therapies could firstly be introduced through the private system. What are the core differences to follow with such a strategy? What are the specifics of the private health insurances? And are there examples of such a market access pathway?

Dr. Stefan Walzer and Dr. Sebastian Biermann, representative of the Association of the private health insurance funds are discussing these questions and beyond.

Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: https://lnkd.in/dZtyKw8B

MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: https://lnkd.in/dDCTND2

#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #negotiations
36 min
February 01, 2022 How can a company derive the optimal price for their medical product, Dr. Renato Dellamano?
What are drivers of pricing and ultimately negotiations? How can a global strategy best be implemented in individual countries? How do payers react to different prices? And finally the two pricing experts Dr. Stefan Walzer and Dr. Renato Dellamano discuss philosophically whether pricing is rather an art or science…
Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: https://lnkd.in/dZtyKw8B

MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de
33 min
January 15, 2022 How do innovations reach patients in German hospitals, Dr. Sebastian Casu?
How important are the famous NUBs, OPS and DRG values? How can innovations reach patients beyond administrative barriers? What are the next steps in terms of digitalization of health care in Germany? Dr. Stefan Walzer and Dr. Sebastian Casu – medical doctor and medical influencer - are continuing the conversation about inpatient market access processes with a strong focus on bed-side innovation including digitalization of healthcare. This episode is linked to episode 9 with Willi Wöllner and the hospital business administration perspective (from January 1 2022).

Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: https://lnkd.in/dZtyKw8B

MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de
33 min
January 01, 2022 How does hospital funding work in Germany, Willi Wöllner?
How does reimbursement work in the German hospital setting and how are hospitals organized doing such negotiations? What is a NUB and how does this relate to annual hospital budget discussions with the health insurance funds? Can industry really take part in this process?
Dr. Stefan Walzer and the experienced hospital adminstrator Willi Wöllner are going deep on inpatient settings from a business perspective. Part II from a medical perspective will follow in the next episode with Dr. Sebastian Casu.
Take the chance to stay connected and subscribe with your favorite podcasting platform.
For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de
37 min
December 15, 2021 Prof. Dr. Jürgen Wasem - What happens, when negotiations fail?
Who could be better to tell us the real insights, how the arbitration board works than Prof. Dr. Juergen Wasem, the former head of the AMNOG arbitration board and the current head of the DiGA arbitration board.
In this wide ranging conversation Dr. Stefan Walzer confronted Prof. Wasem with in-depth issues to take the arbitration board as well into strategic considerations.
Take the chance to stay connected and subscribe with your favorite podcasting platform.
For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de
39 min
December 01, 2021 Dr. Michael Zuercher - Commercial attractiveness of the Swiss health care market – success starts with market access.
In this Podcast episode Dr. Stefan Walzer confronts the Swiss expert Michael Zuercher with his perspective on Market Access to Switzerland. Furthermore they are discussing the right commercial planning in the context of a successful market access submission in Switzerland. Even though the Swiss market is low in volumes due to a limited number of patients in comparison to other European countries, it is a very attractive market with unique entrance options such as “early paid access”!
Take the chance to stay connected and subscribe with your favorite podcasting platform.
For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de
33 min
November 15, 2021 Prof. Peter Zweifel & Door Vonk - Digital innovation - from theory into practice!
In this Podcast episode, Dr. Stefan Walzer is discussing innovation theory from an economics perspective together with Prof. Peter Zweifel from the University of Zürich. Afterwards theory will be confronted with real life! Door Vonk talsk about founding the company „Tired of Cancer“ in the context of innovation theory.
Take the chance to stay connected and subscribe with your favorite podcasting platform.
For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de
1 hr 2 min
November 01, 2021 Bibiane Schulte-Bosse - How to fight well in AMNOG negotiations.
In this Podcast episode, Dr. Stefan Walzer is explaining the details of the price negotiations within the AMNOG process together with negotiating expert and lawyer Bibiane Schulte-Bosse.
Get into the hot areas of AMNOG – the negotiations and let us know in case you might have any questions.
Take the chance to stay connected and subscribe with your favorite podcasting platform.
For more information about MArS Market Access and Pricing Strategy visit:
marketaccess-pricingstrategy.de
35 min
October 15, 2021 Prof. Dr. David Matusiewicz & Dr. Anne Sophie Geier - 1 year DIGAs. Is the "fast track process" for digital health applications successful?
In this Podcast episode, Dr. Stefan Walzer is reflecting on 1 year DIGAs
with the leading question whether the "fast track process" for digital health applications is successful?
Additionally, the two digital health experts, Prof. Dr. David Matusiewicz from the FOM Universtity and Dr. Anne Sophie Geier from the head association of digital healthcare SVDGV, will also discuss the status of digitalization in the German health care system.
Get into the latest digital health care discussions and let us know in case you might have any questions.
Take the chance to stay connected and subscribe with your favorite podcasting platform.
For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de
29 min
October 01, 2021 Remo Christen – Early paid access in Switzerland – Switzerland, wonderland??
In this Podcast episode, Dr. Stefan Walzer is discussing the specifics of the Swiss market access & reimbursement specifics including the famous article 71, which allows an early paid access.
Who else could better speak about the Swiss system with him than Remo Christen? Remo is working since > 20 years in the Swiss market access environment in a leading role at Roche’s Swiss affiliate.
In this episode, listeners will learn the specifics of the Swiss culture, the reimbursement process also in comparison to the German AMNOG and why Switzerland is attractive for drug launches.
Subscribe with your favorite podcasting platform.
For more information about MArS Market Access and Pricing Strategy visit:
marketaccess-pricingstrategy.de
35 min

About MAP - Market Access Podcast

From the publisher's feed

Market Access (or alternatively reimbursement) in health care is THE key competence in order to be commercially successful with a new drug, medical device or digital health application. However, given the fact that market access is a complex field involving various disciplines and is an ever-changing field, it is difficult to be up to speed with the different evolvements across the world.

MAP is THE bi-weekly Market Access Podcast provided by MArS Market Access & Pricing Strategy, which is your health care consultancy in the German-speaking markets and allows you to keep up to date with market access , reimbursement and pricing issues in the D-A-CH countries and around the world. With MAP you will get a summary of core market access systems and processes as well as latest changes in regulations including statements and opinions of core decision makers and stakeholders from various countries.

The CEO and founder of MArS is also the driver behind MAP: Dr. Stefan Walzer works in the field of payer strategy, pricing, health economics and reimbursement since 2004 and is the founder and CEO of MArS Market Access & Pricing Strategy GmbH based in Germany. MArS makes it as easy as possible for you to get your Pharmaceutical, MedTech or digital health product to the market and of course get the price it deserves.

Stefan previously worked as a payer consultant for various global pharmaceutical and medical device / diagnostic companies, successfully launching their products across the world. He was the Global Payer Strategy Leader for various products and compounds at F. Hoffmann – La Roche AG, where he successfully developed early payer strategies as well as launching and maintaining the reimbursement process for top brands and early compounds. Stefan is capable in translating the clinical and economic evidence into successful reimbursement submissions and pricing negotiations especially in Austria, Germany and Switzerland. Additionally he teaches market access, pricing and negotiations at the State University of Baden-Wuerttemberg and the University of Applied Sciences Weingarten-Ravensburg (both Germany).

Besides other roles and responsibilities. Stefan was the head of the committee “Inpatient care” of the German Health Economic Association (DGGÖ). Furthermore he is also a member of the Austrian Health Economic Association (ATHEA) and the Swiss Health Economic Association (SGGÖ). Additionally, he is a member of the Access Advisory Committee of the Global Pneumonia Prevention Coalition.

Stefan received a Master of Science in Economics from the University of Tuebingen (Germany), a PhD in Health Economics from the University of Zurich (Switzerland) and a post-graduate diploma in Clinical Trials from the London School of Hygiene and Tropical Medicine (UK). He is co-author of more than 40 peer-reviewed scientific articles and more than 300 scientific abstracts.